|
Equity Method Investments - Investment in Betazone Laboratories, LLC (Details) (USD $)
|
12 Months Ended | |
|---|---|---|
|
Dec. 31, 2012
|
Dec. 31, 2011
|
|
| Balance sheet | ||
| Current assets | $ 3,825 | $ 110,093 |
| Current Liabilities | 301,864 | 131,672 |
| Statement of operations | ||
| Revenues | 40,002 | 315,346 |
| Net income (loss) | $ (272,935) | $ (102,047) |
| X | ||||||||||
|
- Definition
Amount of significant additions in the period in other assets (current, noncurrent, or unclassified). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of income (loss) from continuing operations attributable to the parent. Also defined as revenue less expenses and taxes from ongoing operations before extraordinary items but after deduction of those portions of income or loss from continuing operations that are allocable to noncontrolling interests. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The increase (decrease) during the reporting period in other current operating liabilities not separately disclosed in the statement of cash flows. No definition available.
|
| X | ||||||||||
|
- Definition
Other revenues from oil and gas producing activities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|